Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2000
09/12/2000US6117422 Genetic engineering
09/12/2000US6117421 Method for promoting cell growth and immunosuppression using chaperonin
09/12/2000US6116237 Methods of dry powder inhalation
09/12/2000CA2051375C Process and compositions for the isolation of human relaxin
09/12/2000CA2020209C Low viscosity, highly concentrated surfactant suspension
09/12/2000CA1341097C Factor viii binding domain of von willebrand factor
09/12/2000CA1341095C Cdna coding for the human von willebrand factor, plasmids or phages with such a cdna coding or fragments thereof respectively, micro-organisms and animal or human cell which contain such plasmids or phages, preparation of proteins by the cultivation of the above mentioned hosts, the obtained proteins and pharmaceutical compositions containing a biologically
09/08/2000WO2000052467A1 Methods of determining altered ndpk functions
09/08/2000WO2000052462A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities
09/08/2000WO2000052205A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
09/08/2000WO2000052186A1 Means and methods for fibroblast-like or macrophage-like cell transduction
09/08/2000WO2000052184A1 Anti-neoplastic compositions and uses thereof
09/08/2000WO2000052178A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
09/08/2000WO2000052175A1 Histidine protein-phosphatase
09/08/2000WO2000052167A1 Angiopoietin-related protein and nucleic acids
09/08/2000WO2000052160A1 Human serpin proteins
09/08/2000WO2000052159A1 Methods and reagents for inhibiting proliferation of smooth muscle cells
09/08/2000WO2000052158A1 Methods and reagents for inhibiting angiogenesis
09/08/2000WO2000052157A1 Tumor-associated antigen
09/08/2000WO2000052154A2 Methods and reagents for decreasing clinical reaction to allergy
09/08/2000WO2000052149A1 Introducing a biological material into a patient
09/08/2000WO2000052148A2 Substances for controlling fertility
09/08/2000WO2000052144A1 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
09/08/2000WO2000052057A1 Crystals and structural coordinate of protein complex and utilisation of the structural coordinate
09/08/2000WO2000052056A2 Anti-plasmodium compositions and methods of use
09/08/2000WO2000052054A2 Antibodies for cancer therapy and diagnosis
09/08/2000WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
09/08/2000WO2000052049A2 A method for purifying human growth hormone
09/08/2000WO2000052048A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
09/08/2000WO2000052047A2 Human dickkopf-related protein and nucleic acid molecules and uses therefor
09/08/2000WO2000052046A1 Immunomodulating glycopeptide
09/08/2000WO2000052044A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
09/08/2000WO2000052041A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
09/08/2000WO2000052039A2 Lectomedin materials and methods
09/08/2000WO2000052037A1 Echinocandin/carbohydrate complexes
09/08/2000WO2000052036A1 Formation and anion-exchange of crystalline echinocandin ammonium salts
09/08/2000WO2000052034A2 Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
09/08/2000WO2000052033A1 Novel cyclic tetrapeptide derivatives and use thereof as drugs
09/08/2000WO2000052032A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors
09/08/2000WO2000052030A1 Rflat-1: a transcription factor that activates rantes gene expression
09/08/2000WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b)
09/08/2000WO2000052025A1 Q16
09/08/2000WO2000052024A1 POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ENCODING HUMAN ORGANIC ANION TRANSPORTER 6(hOATP6) AND SCREENING METHODS THEREOF
09/08/2000WO2000052022A1 Secreted proteins and nucleic acids encoding them
09/08/2000WO2000051647A2 Animal model of allergies
09/08/2000WO2000051643A1 Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
09/08/2000WO2000051642A1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
09/08/2000WO2000051632A2 COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE
09/08/2000WO2000051631A2 Pegylated alpha interferon for hiv therapy
09/08/2000WO2000051630A2 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent
09/08/2000WO2000051629A1 Preparations stabilized over long time
09/08/2000WO2000051628A2 Methods of modulating lipid metabolism and storage
09/08/2000WO2000051627A1 Functional oral preparations
09/08/2000WO2000051625A1 Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
09/08/2000WO2000051624A2 Methods and compositions useful in inhibiting apoptosis
09/08/2000WO2000051623A2 Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
09/08/2000WO2000051621A1 Method for validating/invalidating target(s) and pathways
09/08/2000WO2000051619A1 Mucin containing ophthalmic preparations
09/08/2000WO2000051597A1 Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
09/08/2000WO2000051583A2 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists
09/08/2000WO2000051567A1 Processes for making pharmaceutical oral ecb formulations and compositions
09/08/2000WO2000051564A1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
09/08/2000WO2000051430A1 Human fas
09/08/2000WO2000036097A3 Methods for regulating vascularization using gef containing nek-like kinase (gnk)
09/08/2000WO2000035407A3 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
09/08/2000WO2000029583A3 Immunoglobulin superfamily proteins
09/08/2000WO2000027873A3 Interleukin-2 binding protein from arthropods
09/08/2000WO2000027418A3 A method for treating tissue damaged from ischemia
09/08/2000WO2000027414A3 Inhibition of the formation of vascular hyperpermeability
09/08/2000WO2000023590A3 INHIBITION OF CD40-MEDIATED NFλB ACTIVATION
09/08/2000WO2000021547A3 Utilization of proteolytic enzymes to influence hyperactive t cells
09/08/2000WO2000020026A3 Compositions and methods for inhibiting angiogenesis
09/08/2000WO2000019883A3 Compositions and methods of disease diagnosis and therapy
09/08/2000WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof
09/08/2000WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies
09/08/2000WO2000012720A3 Elongase genes and uses thereof
09/08/2000WO2000012702A3 Human genes differentially expressed in colorectal cancer
09/08/2000WO2000012546A9 MAMMALIAN elk POTASSIUM CHANNEL GENES
09/08/2000WO2000009709A3 Proteases and associated proteins
09/08/2000WO2000000604A9 Methods and compositions for modulating spermatogenesis
09/08/2000WO1999064595A9 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
09/08/2000WO1999053961A9 Peptides for efficient gene transfer
09/08/2000WO1999049019A8 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
09/08/2000CA2371934A1 Copper agonist that binds on the copper binding site of app and/or exerts and inhibiting effect on the release of amyloid a.beta. peptide
09/08/2000CA2371846A1 Methods and reagents for inhibiting proliferation of smooth muscle cells
09/08/2000CA2368539A1 Tumor-associated antigen
09/08/2000CA2366071A1 Lectomedin materials and methods
09/08/2000CA2366062A1 Human dickkopf-related protein and nucleic acid molecules and uses therefor
09/08/2000CA2366055A1 Method for validating/invalidating target(s) and pathways
09/08/2000CA2364592A1 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
09/08/2000CA2364495A1 Histidine protein-phosphatase
09/08/2000CA2364471A1 Human serpin proteins
09/08/2000CA2364463A1 Introducing a biological material into a patient
09/08/2000CA2364279A1 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent
09/08/2000CA2364169A1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
09/08/2000CA2364063A1 Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
09/08/2000CA2364030A1 A method for purifying human growth hormone
09/08/2000CA2363961A1 Crystals and structural coordinate of protein complex and utilisation of the structural coordinate
09/08/2000CA2363957A1 Immunomodulating glycopeptide
09/08/2000CA2363488A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities
1 ... 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 ... 3163